Towards sustainable mental health promotion: Trial-based health-economic evaluation of a positive psychology intervention versus usual care

Marijke Schotanus-Dijkstra* (Corresponding Author), Constance H.C. Drossaert, Marcel E. Pieterse, Jan A. Walburg, Ernst T. Bohlmeijer, Filip Smit

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
19 Downloads (Pure)

Abstract

Background: Mental well-being could be promoted and protected by positive psychology (PP) based interventions. Such interventions may be appealing for people at risk of anxiety and depressive disorders, but health-economic evaluations are scarce. The aim was to examine the cost-effectiveness of a PP intervention. Methods: Participants with suboptimal levels of mental well-being were randomly assigned to an email guided PP-intervention (n = 137) or a wait-list control group (n = 138) with access to usual care (UC). At baseline and 6 months follow-up, data were collected on health care costs. Outcomes of interest were flourishing mental health and treatment response on anxiety and depressive symptoms. Results: Bootstrapped mean incremental cost-effectiveness ratios were €2359 ($2899) for flourishing, €2959 ($3637) for anxiety and €2578 ($3168) for depression, suggesting appreciable health gains for low additional costs. At a willingness to pay ceiling of €10,000 ($12,290) for a treatment response, the probability that the intervention is deemed cost-effective ranged between 90 and 93%. Conclusions: The guided PP intervention appears to be a promising strategy as seen from both a public health and a health-economic perspective, especially when there is some willingness to pay. When the PP-intervention is scaled up, then outcome monitoring is recommended to better guarantee the longer term cost-effectiveness of the intervention.

Original languageEnglish
Article number265
JournalBMC psychiatry
Volume18
Issue number1
DOIs
Publication statusPublished - 23 Aug 2018

Fingerprint

Health Promotion
Cost-Benefit Analysis
Mental Health
Psychology
Health
Anxiety
Depression
Costs and Cost Analysis
Depressive Disorder
Anxiety Disorders
Health Care Costs
Public Health
Economics
Control Groups

Keywords

  • Cost-effectiveness
  • Guided self-help
  • Mental well-being
  • Positive psychology
  • Prevention
  • Randomized controlled trial

Cite this

@article{9da8075bb039417ba70881da223e4618,
title = "Towards sustainable mental health promotion: Trial-based health-economic evaluation of a positive psychology intervention versus usual care",
abstract = "Background: Mental well-being could be promoted and protected by positive psychology (PP) based interventions. Such interventions may be appealing for people at risk of anxiety and depressive disorders, but health-economic evaluations are scarce. The aim was to examine the cost-effectiveness of a PP intervention. Methods: Participants with suboptimal levels of mental well-being were randomly assigned to an email guided PP-intervention (n = 137) or a wait-list control group (n = 138) with access to usual care (UC). At baseline and 6 months follow-up, data were collected on health care costs. Outcomes of interest were flourishing mental health and treatment response on anxiety and depressive symptoms. Results: Bootstrapped mean incremental cost-effectiveness ratios were €2359 ($2899) for flourishing, €2959 ($3637) for anxiety and €2578 ($3168) for depression, suggesting appreciable health gains for low additional costs. At a willingness to pay ceiling of €10,000 ($12,290) for a treatment response, the probability that the intervention is deemed cost-effective ranged between 90 and 93{\%}. Conclusions: The guided PP intervention appears to be a promising strategy as seen from both a public health and a health-economic perspective, especially when there is some willingness to pay. When the PP-intervention is scaled up, then outcome monitoring is recommended to better guarantee the longer term cost-effectiveness of the intervention.",
keywords = "Cost-effectiveness, Guided self-help, Mental well-being, Positive psychology, Prevention, Randomized controlled trial",
author = "Marijke Schotanus-Dijkstra and Drossaert, {Constance H.C.} and Pieterse, {Marcel E.} and Walburg, {Jan A.} and Bohlmeijer, {Ernst T.} and Filip Smit",
year = "2018",
month = "8",
day = "23",
doi = "10.1186/s12888-018-1825-5",
language = "English",
volume = "18",
journal = "BMC psychiatry",
issn = "1471-244X",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Towards sustainable mental health promotion

T2 - Trial-based health-economic evaluation of a positive psychology intervention versus usual care

AU - Schotanus-Dijkstra, Marijke

AU - Drossaert, Constance H.C.

AU - Pieterse, Marcel E.

AU - Walburg, Jan A.

AU - Bohlmeijer, Ernst T.

AU - Smit, Filip

PY - 2018/8/23

Y1 - 2018/8/23

N2 - Background: Mental well-being could be promoted and protected by positive psychology (PP) based interventions. Such interventions may be appealing for people at risk of anxiety and depressive disorders, but health-economic evaluations are scarce. The aim was to examine the cost-effectiveness of a PP intervention. Methods: Participants with suboptimal levels of mental well-being were randomly assigned to an email guided PP-intervention (n = 137) or a wait-list control group (n = 138) with access to usual care (UC). At baseline and 6 months follow-up, data were collected on health care costs. Outcomes of interest were flourishing mental health and treatment response on anxiety and depressive symptoms. Results: Bootstrapped mean incremental cost-effectiveness ratios were €2359 ($2899) for flourishing, €2959 ($3637) for anxiety and €2578 ($3168) for depression, suggesting appreciable health gains for low additional costs. At a willingness to pay ceiling of €10,000 ($12,290) for a treatment response, the probability that the intervention is deemed cost-effective ranged between 90 and 93%. Conclusions: The guided PP intervention appears to be a promising strategy as seen from both a public health and a health-economic perspective, especially when there is some willingness to pay. When the PP-intervention is scaled up, then outcome monitoring is recommended to better guarantee the longer term cost-effectiveness of the intervention.

AB - Background: Mental well-being could be promoted and protected by positive psychology (PP) based interventions. Such interventions may be appealing for people at risk of anxiety and depressive disorders, but health-economic evaluations are scarce. The aim was to examine the cost-effectiveness of a PP intervention. Methods: Participants with suboptimal levels of mental well-being were randomly assigned to an email guided PP-intervention (n = 137) or a wait-list control group (n = 138) with access to usual care (UC). At baseline and 6 months follow-up, data were collected on health care costs. Outcomes of interest were flourishing mental health and treatment response on anxiety and depressive symptoms. Results: Bootstrapped mean incremental cost-effectiveness ratios were €2359 ($2899) for flourishing, €2959 ($3637) for anxiety and €2578 ($3168) for depression, suggesting appreciable health gains for low additional costs. At a willingness to pay ceiling of €10,000 ($12,290) for a treatment response, the probability that the intervention is deemed cost-effective ranged between 90 and 93%. Conclusions: The guided PP intervention appears to be a promising strategy as seen from both a public health and a health-economic perspective, especially when there is some willingness to pay. When the PP-intervention is scaled up, then outcome monitoring is recommended to better guarantee the longer term cost-effectiveness of the intervention.

KW - Cost-effectiveness

KW - Guided self-help

KW - Mental well-being

KW - Positive psychology

KW - Prevention

KW - Randomized controlled trial

UR - http://www.scopus.com/inward/record.url?scp=85052317385&partnerID=8YFLogxK

U2 - 10.1186/s12888-018-1825-5

DO - 10.1186/s12888-018-1825-5

M3 - Article

AN - SCOPUS:85052317385

VL - 18

JO - BMC psychiatry

JF - BMC psychiatry

SN - 1471-244X

IS - 1

M1 - 265

ER -